Literature DB >> 21555856

Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape.

Estibaliz Lazaro1, Carl Kadie, Pamela Stamegna, Shao Chong Zhang, Pauline Gourdain, Nicole Y Lai, Mei Zhang, Sergio A Martinez, David Heckerman, Sylvie Le Gall.   

Abstract

Induction of virus-specific CD8⁺ T cell responses is critical for the success of vaccines against chronic viral infections. Despite the large number of potential MHC-I-restricted epitopes located in viral proteins, MHC-I-restricted epitope generation is inefficient, and factors defining the production and presentation of MHC-I-restricted viral epitopes are poorly understood. Here, we have demonstrated that the half-lives of HIV-derived peptides in cytosol from primary human cells were highly variable and sequence dependent, and significantly affected the efficiency of cell recognition by CD8⁺ T cells. Furthermore, multiple clinical isolates of HLA-associated HIV epitope variants displayed reduced half-lives relative to consensus sequence. This decreased cytosolic peptide stability diminished epitope presentation and CTL recognition, illustrating a mechanism of immune escape. Chaperone complexes including Hsp90 and histone deacetylase HDAC6 enhanced peptide stability by transient protection from peptidase degradation. Based on empirical results with 166 peptides, we developed a computational approach utilizing a sequence-based algorithm to estimate the cytosolic stability of antigenic peptides. Our results identify sequence motifs able to alter the amount of peptide available for loading onto MHC-I, suggesting potential new strategies to modulate epitope production from vaccine immunogens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555856      PMCID: PMC3104749          DOI: 10.1172/JCI44932

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.

Authors:  Yoshiharu Kawaguchi; Jeffrey J Kovacs; Adam McLaurin; Jeffery M Vance; Akihiro Ito; Tso Pang Yao
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

2.  Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

Authors:  Eric Reits; Alexander Griekspoor; Joost Neijssen; Tom Groothuis; Kees Jalink; Peter van Veelen; Hans Janssen; Jero Calafat; Jan Wouter Drijfhout; Jacques Neefjes
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

3.  Quantitating protein synthesis, degradation, and endogenous antigen processing.

Authors:  Michael F Princiotta; Diana Finzi; Shu-Bing Qian; James Gibbs; Sebastian Schuchmann; Frank Buttgereit; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

Review 4.  The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.

Authors:  Alfred L Goldberg; Paolo Cascio; Tomo Saric; Kenneth L Rock
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

5.  Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation.

Authors:  Carla A Herberts; Joost J Neijssen; Jolanda de Haan; Lennert Janssen; Jan Wouter Drijfhout; Eric A Reits; Jacques J Neefjes
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

6.  De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.

Authors:  Todd M Allen; Xu G Yu; Elizabeth T Kalife; Laura L Reyor; Mathias Lichterfeld; Mina John; Michael Cheng; Rachel L Allgaier; Stanley Mui; Nicole Frahm; Galit Alter; Nancy V Brown; Mary N Johnston; Eric S Rosenberg; Simon A Mallal; Christian Brander; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase.

Authors:  T Saric; J Beninga; C I Graef; T N Akopian; K L Rock; A L Goldberg
Journal:  J Biol Chem       Date:  2001-07-30       Impact factor: 5.157

8.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

9.  Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.

Authors:  Xu G Yu; Marylyn M Addo; Eric S Rosenberg; William R Rodriguez; Paul K Lee; Cecily A Fitzpatrick; Mary N Johnston; Daryld Strick; Philip J R Goulder; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation.

Authors:  Ian A York; Annie X Y Mo; Kristen Lemerise; Wanyong Zeng; Yuelei Shen; Carmela R Abraham; Tomo Saric; Alfred L Goldberg; Kenneth L Rock
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

View more
  28 in total

1.  Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.

Authors:  Tomohiro Akahoshi; Takayuki Chikata; Yoshiko Tamura; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.

Authors:  Julie Boucau; Julien Madouasse; Georgio Kourjian; Christopher S Carlin; Daniel Wambua; Matthew J Berberich; Sylvie Le Gall
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

3.  High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Authors:  Christoph T Berger; Nicole Frahm; David A Price; Beatriz Mothe; Musie Ghebremichael; Kari L Hartman; Leah M Henry; Jason M Brenchley; Laura E Ruff; Vanessa Venturi; Florencia Pereyra; John Sidney; Alessandro Sette; Daniel C Douek; Bruce D Walker; Daniel E Kaufmann; Christian Brander
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.

Authors:  Diana Y Chen; Arumugam Balamurugan; Hwee L Ng; William G Cumberland; Otto O Yang
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

5.  Sequence-specific alterations of epitope production by HIV protease inhibitors.

Authors:  Georgio Kourjian; Yang Xu; Ijah Mondesire-Crump; Mariko Shimada; Pauline Gourdain; Sylvie Le Gall
Journal:  J Immunol       Date:  2014-03-10       Impact factor: 5.422

Review 6.  Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.

Authors:  Karrune V Woan; Eva Sahakian; Eduardo M Sotomayor; Edward Seto; Alejandro Villagra
Journal:  Immunol Cell Biol       Date:  2011-11-22       Impact factor: 5.126

7.  Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.

Authors:  Jens Dinter; Pauline Gourdain; Nicole Y Lai; Ellen Duong; Edith Bracho-Sanchez; Marijana Rucevic; Paul H Liebesny; Yang Xu; Mariko Shimada; Musie Ghebremichael; Daniel G Kavanagh; Sylvie Le Gall
Journal:  J Immunol       Date:  2014-09-17       Impact factor: 5.422

Review 8.  Vaccine design: emerging concepts and renewed optimism.

Authors:  Sebastian K Grimm; Margaret E Ackerman
Journal:  Curr Opin Biotechnol       Date:  2013-03-07       Impact factor: 9.740

9.  A real-time killing assay to follow viral epitope presentation to CD8 T cells.

Authors:  Pauline Gourdain; Julie Boucau; Georgio Kourjian; Nicole Y Lai; Ellen Duong; Sylvie Le Gall
Journal:  J Immunol Methods       Date:  2013-09-20       Impact factor: 2.303

10.  Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.

Authors:  Samir K Lakhashe; Siddappa N Byrareddy; Mingkui Zhou; Barbara C Bachler; Girish Hemashettar; Shiu-Lok Hu; Francois Villinger; James G Else; Shannon Stock; Sandra J Lee; Diego A Vargas-Inchaustegui; Egidio Brocca Cofano; Marjorie Robert-Guroff; Welkin E Johnson; Victoria R Polonis; Donald N Forthal; Erwann P Loret; Robert A Rasmussen; Ruth M Ruprecht
Journal:  Vaccine       Date:  2014-09-20       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.